Drugs / Platelets Rich Plasma
Platelets Rich Plasma
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05395845 | Jun → Dec 2022 | anosmia | Aya abdelnasser hassani | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02923310 | Nov 2013 → Sep 2016 | osteoarthritis | University of Campinas, Brazil | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05884151 Comparator | Nov 2022 → Apr 2023 | hyperpigmentation of the skin | Combined Military Hospital Abbottabad | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelets rich plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05884151 ↗ |
| Known as | Platelet-Rich Plasma | “Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2” NCT05395845 ↗ |
| Known as | PRP | “One of therapies can be used in ttt of smell disorders ( Platelet \_rich plasma) PRP is a process in which a small amount of blood from test subject is separated by special...” NCT05395845 ↗1“Group B 30 patients prescribed with PRP (1ml) intra-dermally PRP was obtained manually by a two-step procedure using a centrifuge machine.” NCT05884151 ↗ |
| Modality | Protein / enzyme biologic | “growth factors derived from autologous platelets” NCT02923310 ↗ |
| Route | Other | “PRP (1ml) intra-dermally” NCT05884151 ↗ |